Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A single center, randomized, single blind, placebo-controlled phase Ib/IIa clinical trial for the safety and efficacy of ACT001 combined with radiotherapy for brain metastases from solid tumors

X
Trial Profile

A single center, randomized, single blind, placebo-controlled phase Ib/IIa clinical trial for the safety and efficacy of ACT001 combined with radiotherapy for brain metastases from solid tumors

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 15 Jul 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ACT 001 (Primary)
  • Indications Advanced breast cancer; Liver cancer; Malignant melanoma; Non-small cell lung cancer; Small cell lung cancer; Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Accendatech
  • Most Recent Events

    • 07 Jun 2022 Results (As of Dec 31st, 2021, n=22)presented at the 58th Annual Meeting of the American Society of Clinical Oncology
    • 01 Dec 2020 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top